Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197315711> ?p ?o ?g. }
- W3197315711 endingPage "1163" @default.
- W3197315711 startingPage "1163" @default.
- W3197315711 abstract "The Coronavirus disease 2019 (COVID-19) pandemic has represented an unprecedented challenge for humankind from health, economic, and social viewpoints. In February 2020, Italy was the first western country to be deeply hit by the pandemic and suffered the highest case/fatality rate among western countries. Brand new anti-COVID-19 vaccines have been developed and made available in <1-year from the viral sequence publication. Patients with compromised immune systems, such as autoimmune-autoinflammatory disorders (AIAIDs), primary (PIDs) and secondary (SIDs) immunodeficiencies, have received careful attention for a long time regarding their capacity to safely respond to traditional vaccines. The Italian Immunological Societies, therefore, have promptly faced the issues of safety, immunogenicity, and efficacy/effectiveness of the innovative COVID-19 vaccines, as well as priority to vaccine access, in patients with AIADs, PIDs, and SIDs, by organizing an ad-hoc Task Force. Patients with AIADs, PIDs, and SIDs: (1) Do not present contraindications to COVID-19 vaccines if a mRNA vaccine is used and administered in a stabilized disease phase without active infection. (2) Should usually not discontinue immunosuppressive therapy, which may be modulated depending on the patient's clinical condition. (3) When eligible, should have a priority access to vaccination. In fact, immunizing these patients may have relevant social/health consequences, since these patients, if infected, may develop chronic infection, which prolongs viral spread and facilitates the emergence of viral variants." @default.
- W3197315711 created "2021-09-13" @default.
- W3197315711 creator A5005421553 @default.
- W3197315711 creator A5012096745 @default.
- W3197315711 creator A5012195468 @default.
- W3197315711 creator A5015789010 @default.
- W3197315711 creator A5016770644 @default.
- W3197315711 creator A5016933710 @default.
- W3197315711 creator A5024513740 @default.
- W3197315711 creator A5029504906 @default.
- W3197315711 creator A5029852174 @default.
- W3197315711 creator A5037101918 @default.
- W3197315711 creator A5059468462 @default.
- W3197315711 creator A5080570898 @default.
- W3197315711 creator A5091577314 @default.
- W3197315711 date "2021-09-04" @default.
- W3197315711 modified "2023-09-27" @default.
- W3197315711 title "Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies" @default.
- W3197315711 cites W1530220307 @default.
- W3197315711 cites W1584352747 @default.
- W3197315711 cites W1960890728 @default.
- W3197315711 cites W2105206118 @default.
- W3197315711 cites W2117625373 @default.
- W3197315711 cites W2155460734 @default.
- W3197315711 cites W2157134939 @default.
- W3197315711 cites W2162448828 @default.
- W3197315711 cites W2169983987 @default.
- W3197315711 cites W2193557615 @default.
- W3197315711 cites W2292472819 @default.
- W3197315711 cites W2395157541 @default.
- W3197315711 cites W2586027079 @default.
- W3197315711 cites W2588412528 @default.
- W3197315711 cites W2791035020 @default.
- W3197315711 cites W2883084708 @default.
- W3197315711 cites W2883162961 @default.
- W3197315711 cites W2899411597 @default.
- W3197315711 cites W2963064076 @default.
- W3197315711 cites W2967124351 @default.
- W3197315711 cites W2972635716 @default.
- W3197315711 cites W3011701213 @default.
- W3197315711 cites W3012721127 @default.
- W3197315711 cites W3018910405 @default.
- W3197315711 cites W3025435356 @default.
- W3197315711 cites W3027138240 @default.
- W3197315711 cites W3045724532 @default.
- W3197315711 cites W3046061621 @default.
- W3197315711 cites W3081892744 @default.
- W3197315711 cites W3083750089 @default.
- W3197315711 cites W3086493104 @default.
- W3197315711 cites W3088841124 @default.
- W3197315711 cites W3090857960 @default.
- W3197315711 cites W3092151577 @default.
- W3197315711 cites W3094009122 @default.
- W3197315711 cites W3102328262 @default.
- W3197315711 cites W3102798166 @default.
- W3197315711 cites W3108735877 @default.
- W3197315711 cites W3111255098 @default.
- W3197315711 cites W3111590711 @default.
- W3197315711 cites W3112028440 @default.
- W3197315711 cites W3112389441 @default.
- W3197315711 cites W3115737775 @default.
- W3197315711 cites W3118654820 @default.
- W3197315711 cites W3121742973 @default.
- W3197315711 cites W3127329393 @default.
- W3197315711 cites W3128389767 @default.
- W3197315711 cites W3131011903 @default.
- W3197315711 cites W3132479927 @default.
- W3197315711 cites W3133327867 @default.
- W3197315711 cites W3133532742 @default.
- W3197315711 cites W3133680184 @default.
- W3197315711 cites W3133819496 @default.
- W3197315711 cites W3134208712 @default.
- W3197315711 cites W3134446480 @default.
- W3197315711 cites W3134470622 @default.
- W3197315711 cites W3135734644 @default.
- W3197315711 cites W3136477267 @default.
- W3197315711 cites W3136570200 @default.
- W3197315711 cites W3137149656 @default.
- W3197315711 cites W3137189552 @default.
- W3197315711 cites W3137769009 @default.
- W3197315711 cites W3139490202 @default.
- W3197315711 cites W3139533040 @default.
- W3197315711 cites W3141087105 @default.
- W3197315711 cites W3141854134 @default.
- W3197315711 cites W3142246475 @default.
- W3197315711 cites W3153508314 @default.
- W3197315711 cites W3154877986 @default.
- W3197315711 cites W3154888372 @default.
- W3197315711 cites W3154998622 @default.
- W3197315711 cites W3155323546 @default.
- W3197315711 cites W3155376666 @default.
- W3197315711 cites W3155604755 @default.
- W3197315711 cites W3156343712 @default.
- W3197315711 cites W3157162195 @default.
- W3197315711 cites W3157184104 @default.
- W3197315711 cites W3157453497 @default.
- W3197315711 cites W3157709232 @default.
- W3197315711 cites W3158032196 @default.